Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Godfrey J, Mei M, Chen L, Song JY, Bedell V, Budde E, Armenian S, Puverel S, Nikolaenko L, Chen R, Daniels S, Kennedy N, Peters L, Rosen ST, Forman SJ, Popplewell LL, Kwak LW, Herrera AF.
Godfrey J, et al. Among authors: armenian s.
Haematologica. 2024 Feb 1;109(2):533-542. doi: 10.3324/haematol.2023.283002.
Haematologica. 2024.
PMID: 37470137
Free PMC article.
Clinical Trial.